Prospective evaluation of real-world safety, symptoms improvement and adherence to mavacamten among Iranian patients with hypertrophic obstructive cardiomyopathy (PERSIA-HOCM): protocol of a multicentre observational study.
- DOI
- 10.1136/bmjopen-2026-124273
- Published
- 2026 Sep 3
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2026-124273,
title = {Prospective evaluation of real-world safety, symptoms improvement and adherence to mavacamten among Iranian patients with hypertrophic obstructive cardiomyopathy (PERSIA-HOCM): protocol of a multicentre observational study.},
author = {Ghaseminejad-Raeini A and Karimi MA and Shirinezhad A and Aslani M and Soheili A and Ghaderi A and Haghjoo M and Bakhshandeh H and Naderi N},
year = {2026},
journal = {BMJ open},
doi = {10.1136/bmjopen-2026-124273},
url = {https://doi.org/10.1136/bmjopen-2026-124273}
}RIS
TY - JOUR TI - Prospective evaluation of real-world safety, symptoms improvement and adherence to mavacamten among Iranian patients with hypertrophic obstructive cardiomyopathy (PERSIA-HOCM): protocol of a multicentre observational study. AU - Ghaseminejad-Raeini A AU - Karimi MA AU - Shirinezhad A AU - Aslani M AU - Soheili A AU - Ghaderi A AU - Haghjoo M AU - Bakhshandeh H AU - Naderi N PY - 2026 JO - BMJ open DO - 10.1136/bmjopen-2026-124273 UR - https://doi.org/10.1136/bmjopen-2026-124273 ER -
APA
A, G., MA, K., A, S., M, A., A, S., A, G., M, H., H, B., & N, N. (2026). Prospective evaluation of real-world safety, symptoms improvement and adherence to mavacamten among Iranian patients with hypertrophic obstructive cardiomyopathy (PERSIA-HOCM): protocol of a multicentre observational study.. BMJ open. https://doi.org/10.1136/bmjopen-2026-124273
Source records
- pubmed · retrieved 2026-09-26T05:45:10.933Z